Form 4: Veracyte CFO Rebecca Chambers Reports Tax Withholding Transaction
SEC Form 4 Filing
Rebecca Chambers, CFO of Veracyte, Inc., reports the withholding of common stock to cover tax obligations related to the vesting of Restricted Stock Units.
Summary
- On March 2, 2024, Rebecca Chambers, the Chief Financial Officer of Veracyte, Inc. (VCYT), reported a transaction involving the withholding of 6,112 shares of common stock.
- These shares were withheld to satisfy tax obligations related to the vesting of Restricted Stock Units (RSUs).
- The RSUs were granted on July 19, 2021, March 3, 2022, August 5, 2022, and March 6, 2023.
- Following the transaction, Chambers directly owns 84,717 shares of Veracyte common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it relates to tax obligations of an executive.
Key Dates
| Date | Description |
|---|---|
| July 19, 2021 | Date of one of the Restricted Stock Unit grants. |
| March 3, 2022 | Date of one of the Restricted Stock Unit grants. |
| August 5, 2022 | Date of one of the Restricted Stock Unit grants. |
| March 6, 2023 | Date of one of the Restricted Stock Unit grants. |
| March 2, 2024 | Date of the transaction involving the withholding of shares. |
| March 5, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.